Agile Vaccine Clinical Development Expertise

Accelerating vaccine development to prevent and treat virulent diseases

Vaccine developers worldwide are faced with the challenge of quickly and safely advancing their vaccines through the clinical development and approval process to prevent millions of deaths every year.   Infectious disease pandemics like Ebola, MERS, and COVID-19 come to mind currently, requiring a rapid response to regional or global outbreaks. Equally important are vaccines to prevent or treat cancers, viral, and bacterial infections that impact the length or quality of human lives.  

At Veristat, we have the scientific-minded experts ready to advance your vaccine through the regulatory hurdles, recruitment challenges, and approval process to safely bring vaccines to market, having supported 160+ vaccine projects to date. 

Understanding Vaccine Trials

We understand that vaccine development has a unique set of challenges, so Veristat has assembled an extraordinary team of scientific-minded experts who have planned and executed over 160 vaccine projects and supported numerous marketing applications.  

Whether a vaccine to prevent or treat cancer recurrence or progression, or rapidly responding to an infectious disease outbreak, like the ongoing COVID-19 pandemic, we solve the problems that arise in testing immunotherapy vaccines, live or inactivated viral vaccines, or even the newest DNA vaccines.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:     
Veristat_icon_vaccine

160+ Vaccine Projects
Veristat_icon_oncology-216-1

40+

cancer vaccine projects supported
Veristat_icon_rare-disease-216

35%

vaccines for Rare Diseases

 Cancer and Virus Vaccine Experience

Knowledge From a Broad Range of Vaccine Experience
   Botulinum Vaccine    Lymphoma
   Breast Cancer    Melanoma
   C Difficile    Metastatic Breast Cancer
   Cervical Cancer    Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
   Colorectal Cancer    Non-Small Cell Lung Cancer
   COVID-19    Pancreatic Cancer
   Ebola    Pandemic Flu
   Gastric Cancer    Prostate Cancer
   Glioblastoma    Renal Cell Cancer
   Head and Neck Squamous Cell Carcinoma (HNSCC)    Respiratory Syncytial Virus
   Hepatitis A    Shingles -Varicella-Zoster Virus (VZV)
   Hepatitis B    Smallpox
   Herpes (HSV2)    Thyroid Cancer
   Human Papilloma Virus (HPV)    Typhoid Fever
   Influenza    Vulva Cancer
   Liver Metastasis    Yellow Fever

 

Learn More with These Resources

Newsletter

Is Your Trial Stuck?

Your teams have worked hard to meet your NDA timeline and complete your submission to the FDA only to receive a Refuse to File letter. In response, we stepped in to perform ...

Read

Newsletter

Agile Solutions to Maintain Trial Momentum

As you consider the impact of COVID-19, there are several key strategies to help you maintain momentum, assess your risks, and minimize the delays for ongoing, new, and ...

Read

Case Study

Rapid Response To Ebola Outbreak

When the WHO declared the Ebola Outbreak of 2014 in Africa a Global Health Emergency, Veristat was contacted to quickly set up clinical trial sites. Learn how we overcame ...

Download
Request A Proposal
  • Privacy Policy
  • ©2006 - 2022 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.